Skip to main content

Table 1 Delineation of clinical target volume of nasopharyngeal carcinoma according to various institutions’ practice, international guidelines, and clinical protocols

From: Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation

 

NRG HN001 protocol

Our Institutional protocol

International guidelines

Suggestions based on current study

GTVp + 8 mm + whole NP

GTVp + 8 mm + whole NP

GTVp + 10 mm + whole NP

GTVp + 8 mm + whole NP

T1-2

    

 Lateral

Bilateral parapharyngeal space

Bilateral pterygoid fossa

Bilateral parapharyngeal space

Bilateral lateral pterygoid plates

Bilateral parapharyngeal space

Cover pterygoid muscle by 5 + 5 mm expansion from GTVp only, unless there is gross muscular invasion; Cover the whole muscle in case of invasion of the deep fascia/ epimysium of the pterygoid muscle

Bilateral parapharyngeal space

Bilateral lateral pterygoid plates (including medial pterygoid muscle)

 Anterior

Posterior 1/4 of nasal cavity

Posterior 1/4 of maxillary sinus

At least 5 mm from choana, posterior wall of maxillary sinus

If nasal cavity is involved, then posterior part of ethmoid sinus should be included

Pterygoid process

PP fossa

At least 5 mm from choana, posterior wall of maxillary sinus

Include vomer and the surrounding ethmoid sinus

PP fossa

At least 5 mm from choana, posterior wall of maxillary sinus

Include vomer and the surrounding ethmoid sinus

PP fossa

 Superior

Skull base (including foramen ovale and rotundum bilaterally)

Inferior sphenoid sinus

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Inferior sphenoid sinus

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Inferior sphenoid sinus (1/2)

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Inferior sphenoid sinus (1/2)

 Posterior

Anterior 1/3 clivus

Prevertebral muscle

Anterior 2/3 clivus

Anterior 1/3 clivus

Spare jugular foramen and hypoglossal canal in the absence of extensive posterior-lateral infiltration of primary tumor or high jugular lymphadenopathy

Prevertebral muscle

Anterior 1/3 clivus

Spare jugular foramen and hypoglossal canal in the absence of extensive posterior-lateral infiltration of primary tumor or high jugular lymphadenopathy

 Inferior

Not stated

The caudal border of palatine uvula or the midpoint of C2

If oropharynx involved, the downward at least 10 mm

Not stateda

The caudal border of palatine uvula or the midpoint of C2

If oropharynx involved, the downward at least 10 mm

T3–4

    

 Lateral

Bilateral parapharyngeal space

Bilateral pterygoid fossa

Bilateral parapharyngeal space

Bilateral lateral pterygoid plates

If medial pterygoid muscle involved, then lateral pterygoid muscle should be included

If lateral pterygoid muscle involved, then infratemporal fossa should be included

Bilateral parapharyngeal space

Cover pterygoid muscle by 5 + 5 mm expansion from GTVp only, unless there is gross muscular invasion; Cover the whole muscle in case of invasion of the deep fascia/ epimysium of the pterygoid muscle

Bilateral parapharyngeal space

Bilateral lateral pterygoid plates (including medial pterygoid muscle)

If medial pterygoid muscle involved, then lateral pterygoid muscle should be included

 Anterior

Posterior 1/4 of nasal cavity

Posterior 1/4 of maxillary sinus

At least 5 mm from posterior wall of nasal cavity and maxillary sinus

Include vomer and the surrounding ethmoid sinus

Pterygoid process

PP fossa

At least 5 mm from choana, posterior wall of maxillary sinus

Include vomer and the surrounding ethmoid sinus

If sphenoid sinus involved, then upper part of posterior ethmoid sinus should be covered

PP fossa

At least 5 mm from choana, posterior wall of maxillary sinus

Included posterior part of ethmoid sinus, in case of involvement of posterior nasal cavity or sphenoid sinus

PP fossa

Include inferior orbital fissure in case of involvement of PP fossa

 Superior

Skull base including foramen ovale and rotundum bilaterally

Entire sphenoid sinus

Cavernous sinus (involved side only)

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Entire sphenoid sinus

If sphenoid sinus involved, then posterior part of ethmoid sinus

If posterior ethmoid sinus involved, then anterior ethmoid sinus should be included

Bilateral cavernous sinus

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Entire sphenoid sinus

Cavernous sinus (involved side only)

Skull base including foramen ovale and rotundum, lacerum, petrous apex bilaterally

Entire sphenoid sinus

Included posterior part of ethmoid sinus, in case of involvement of posterior nasal cavity or sphenoid sinus

If posterior ethmoid sinus involved, then anterior sphenoid sinus should be included

Cavernous sinus (involved side only)

 Posterior

Anterior 1/3 clivus (entire if involved)

Prevertebral muscle

Anterior 2/3 clivus (entire if involved)

Anterior 1/3 clivus (entire if involved)

Spare jugular foramen and hypoglossal canal in the absence of extensive posterior-lateral infiltration of primary tumor or high jugular lymphadenopathy

Prevertebral muscle

Anterior 1/3 clivus (entire if involved)

Include jugular foramen in case of extensive posterior-lateral infiltration of primary tumor or high jugular lymphadenopathy

If clivus or jugular foramen involved, then hypoglossal canal should be included

 Inferior

Not stated

The caudal border of palatine uvula or the midpoint of C2

If oropharynx involved, the downward at least 10 mm

Not stateda

The caudal border of palatine uvula or the midpoint of C2

If oropharynx involved, the downward at least 10 mm

  1. The italic words were our suggestions based on the results of current study
  2. PP fossa, pterygopalatine fossa; NP, Nasopharynx; C1, the first cervical vertebra; C2, the second cervical vertebra
  3. aInternational guideline does not state the caudal border of high-risk CTV. However, guidelines recommended setting the caudal limit of primary tumor CTV (GTVp + 5 mm + whole nasopharynx) to the caudal border of C1